{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:05:03Z","timestamp":1780459503854,"version":"3.54.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ucl.2015.04.004","type":"journal-article","created":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T08:18:41Z","timestamp":1437898721000},"page":"299-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Management of Stage I Nonseminomatous Germ Cell Tumors"],"prefix":"10.1016","volume":"42","author":[{"given":"Evan","family":"Kovac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"28","key":"10.1016\/j.ucl.2015.04.004_bib1","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1200\/JCO.2013.51.0479","article-title":"Optimal management of clinical stage I testis cancer: one size does not fit all","volume":"31","author":"de Wit","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"28","key":"10.1016\/j.ucl.2015.04.004_bib2","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1200\/JCO.2012.47.6010","article-title":"Active surveillance is the preferred approach to clinical stage I testicular cancer","volume":"31","author":"Nichols","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2015.04.004_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/annonc\/mdu520","article-title":"Primum non nocere: do we harm stage I testicular cancer patients less by applying adjuvant chemotherapy than by failing to present this option?","volume":"26","author":"Oldenburg","year":"2015","journal-title":"Ann Oncol"},{"issue":"4 Suppl","key":"10.1016\/j.ucl.2015.04.004_bib4","doi-asserted-by":"crossref","first-page":"S444","DOI":"10.1016\/j.urology.2011.02.030","article-title":"Management of low-stage nonseminomatous germ cell tumors of testis: SIU\/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009","volume":"78","author":"Stephenson","year":"2011","journal-title":"Urology"},{"issue":"24","key":"10.1016\/j.ucl.2015.04.004_bib5","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1200\/JCO.2005.08.227","article-title":"Increasing incidence of testicular germ cell tumors among black men in the United States","volume":"23","author":"McGlynn","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2015.04.004_bib6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2214\/ajr.169.2.9242768","article-title":"CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria","volume":"169","author":"Hilton","year":"1997","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.ucl.2015.04.004_bib7","first-page":"1759","article-title":"Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes","volume":"154","author":"Leibovitch","year":"1995","journal-title":"J\u00a0Urol"},{"issue":"12","key":"10.1016\/j.ucl.2015.04.004_bib8","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1200\/JCO.2005.07.132","article-title":"Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome","volume":"23","author":"Stephenson","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2015.04.004_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1200\/JCO.2014.56.2116","article-title":"Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance","volume":"33","author":"Kollmannsberger","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.ucl.2015.04.004_bib10","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/annonc\/mdn170","article-title":"[18F]-FDG-PET in clinical stage I\/II non-seminomatous germ cell tumours: results of the German multicentre trial","volume":"19","author":"de Wit","year":"2008","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.ucl.2015.04.004_bib11","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/(SICI)1097-0142(19970501)79:9<1710::AID-CNCR11>3.0.CO;2-0","article-title":"MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis","volume":"79","author":"Albers","year":"1997","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ucl.2015.04.004_bib12","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1200\/JCO.2003.07.169","article-title":"Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial","volume":"21","author":"Albers","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2015.04.004_bib13","first-page":"579","article-title":"Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors","volume":"155","author":"Albers","year":"1996","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.ucl.2015.04.004_bib14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0959-8049(00)00442-1","article-title":"Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse","volume":"37","author":"Alexandre","year":"2001","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ucl.2015.04.004_bib15","first-page":"1148","article-title":"Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors","volume":"161","author":"Bohlen","year":"1999","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.ucl.2015.04.004_bib16","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/1097-0142(19940815)74:4<1335::AID-CNCR2820740425>3.0.CO;2-T","article-title":"Predictive parameters of biologic behavior of early stage nonseminomatous testicular germ cell tumors","volume":"74","author":"de Riese","year":"1994","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ucl.2015.04.004_bib17","first-page":"620","article-title":"Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumors","volume":"158","author":"Heidenreich","year":"1997","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.ucl.2015.04.004_bib18","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<1002::AID-CNCR27>3.0.CO;2-A","article-title":"Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis","volume":"83","author":"Heidenreich","year":"1998","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ucl.2015.04.004_bib19","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0959-8049(97)00041-5","article-title":"Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer","volume":"33","author":"Klepp","year":"1997","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ucl.2015.04.004_bib20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0936-6555(05)80880-5","article-title":"Risk-related adjuvant chemotherapy for stage I non-seminoma of the testis","volume":"3","author":"Madej","year":"1991","journal-title":"Clin Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2015.04.004_bib21","first-page":"362","article-title":"Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer","volume":"54","author":"Moul","year":"1994","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.ucl.2015.04.004_bib22","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1159\/000019656","article-title":"Prognostic factors in clinical stage I nonseminomatous germ cell testicular tumors: rationale for different risk-adapted treatment","volume":"33","author":"Ondrus","year":"1998","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2015.04.004_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1200\/JCO.1990.8.1.16","article-title":"Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial","volume":"8","author":"Pont","year":"1990","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.ucl.2015.04.004_bib24","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1200\/JCO.1992.10.11.1762","article-title":"Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party","volume":"10","author":"Read","year":"1992","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.ucl.2015.04.004_bib25","first-page":"855","article-title":"Clinical stage I testis cancer: long-term outcome of patients on surveillance","volume":"159","author":"Sogani","year":"1998","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.ucl.2015.04.004_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0009-9260(97)80105-5","article-title":"The role of computed tomographic examination of the pelvis in the management of testicular germ cell tumours","volume":"52","author":"White","year":"1997","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.ucl.2015.04.004_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ucl.2007.02.001","article-title":"Management of clinical stage I nonseminomatous germ cell testicular cancer","volume":"34","author":"Choueiri","year":"2007","journal-title":"Urol Clin North Am"},{"issue":"22","key":"10.1016\/j.ucl.2015.04.004_bib28","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1200\/JCO.2003.01.094","article-title":"Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review","volume":"21","author":"Vergouwe","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2015.04.004_bib29","first-page":"557","article-title":"Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and\/or lymphovascular invasion","volume":"174","author":"Stephenson","year":"2005","journal-title":"J\u00a0Urol"},{"issue":"13","key":"10.1016\/j.ucl.2015.04.004_bib30","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1200\/JCO.2008.18.8953","article-title":"Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program","volume":"27","author":"Tandstad","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2015.04.004_bib31","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.eururo.2010.12.010","article-title":"Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience","volume":"59","author":"Sturgeon","year":"2011","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2015.04.004_bib32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1464-410x.1999.00869.x","article-title":"Late results of surveillance of clinical stage I nonseminoma germ cell testicular tumours: 17 years' experience in a national study in New Zealand","volume":"83","author":"Colls","year":"1999","journal-title":"BJU Int"},{"issue":"15","key":"10.1016\/j.ucl.2015.04.004_bib33","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0959-8049(00)00140-4","article-title":"Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options","volume":"36","author":"Francis","year":"2000","journal-title":"Eur J Cancer"},{"issue":"8554","key":"10.1016\/j.ucl.2015.04.004_bib34","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(87)90889-0","article-title":"Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone","volume":"2","author":"Freedman","year":"1987","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ucl.2015.04.004_bib35","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.1995.13.5.1188","article-title":"Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single-center 10-year experience","volume":"13","author":"Gels","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2015.04.004_bib36","first-page":"472","article-title":"Progression detection of stage I nonseminomatous testis cancer on surveillance: implications for the followup protocol","volume":"161","author":"Sharir","year":"1999","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2015.04.004_bib37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1034\/j.1600-0463.2003.11101111.x","article-title":"Surveillance in stage I testicular cancer","volume":"111","author":"Daugaard","year":"2003","journal-title":"APMIS"},{"issue":"6","key":"10.1016\/j.ucl.2015.04.004_bib38","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/annonc\/mdp473","article-title":"Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy","volume":"21","author":"Kollmannsberger","year":"2010","journal-title":"Ann Oncol"},{"issue":"18S","key":"10.1016\/j.ucl.2015.04.004_bib39","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1200\/jco.2007.25.18_suppl.5021","article-title":"Initial versus recent outcomes with a non-risk adapted surveillance policy in stage I non-seminomatous germ cell tumors (NSGCT)","volume":"25","author":"Duran","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"34","key":"10.1016\/j.ucl.2015.04.004_bib40","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1200\/JCO.2013.53.5831","article-title":"Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort","volume":"32","author":"Daugaard","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2015.04.004_bib41","first-page":"2575","article-title":"Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres","volume":"12","author":"Ernst","year":"2005","journal-title":"Can J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2015.04.004_bib42","doi-asserted-by":"crossref","first-page":"502","DOI":"10.6004\/jnccn.2012.0050","article-title":"Testicular cancer","volume":"10","author":"Motzer","year":"2012","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.ucl.2015.04.004_bib43","first-page":"1184","article-title":"Surveillance programs for early stage non-seminomatous testicular cancer: a practice guideline","volume":"8","author":"Segal","year":"2001","journal-title":"Can J Urol"},{"issue":"2","key":"10.1016\/j.ucl.2015.04.004_bib44","first-page":"627","article-title":"Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography","volume":"181","author":"Tarin","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"11","key":"10.1016\/j.ucl.2015.04.004_bib45","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.2006.08.4889","volume":"25","author":"Rustin","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.ucl.2015.04.004_bib46","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s00330-009-1710-1","article-title":"Comparison of low dose with standard dose abdominal\/pelvic multidetector CT in patients with stage 1 testicular cancer under surveillance","volume":"20","author":"O'Malley","year":"2010","journal-title":"Eur Radiol"},{"issue":"3 Pt 1","key":"10.1016\/j.ucl.2015.04.004_bib47","first-page":"768","article-title":"Compliance of clinical stage I nonseminomatous germ cell tumor patients with surveillance","volume":"160","author":"Hao","year":"1998","journal-title":"J\u00a0Urol"},{"issue":"10","key":"10.1016\/j.ucl.2015.04.004_bib48","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<2109::AID-CNCR22>3.0.CO;2-Y","article-title":"Testicular germ cell tumors in patients with human immunodeficiency virus infection","volume":"77","author":"Hentrich","year":"1996","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ucl.2015.04.004_bib49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1200\/JCO.2009.22.0400","article-title":"Defining the optimal treatment for clinical stage I nonseminomatous germ cell testicular cancer using decision analysis","volume":"28","author":"Nguyen","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.ucl.2015.04.004_bib50","first-page":"1788","article-title":"Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma","volume":"163","author":"Foster","year":"2000","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.ucl.2015.04.004_bib51","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.eururo.2010.08.032","article-title":"Retroperitoneal lymph node dissection with no adjuvant chemotherapy in clinical stage I nonseminomatous germ cell tumours: long-term outcome and analysis of risk factors of recurrence","volume":"58","author":"Nicolai","year":"2010","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ucl.2015.04.004_bib52","first-page":"937","article-title":"Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer","volume":"177","author":"Eggener","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2015.04.004_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.eururo.2008.09.027","article-title":"Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection","volume":"55","author":"Heidenreich","year":"2009","journal-title":"Eur Urol"},{"issue":"9 Pt B","key":"10.1016\/j.ucl.2015.04.004_bib54","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1464-410X.2009.08861.x","article-title":"Retroperitoneal lymph node dissection: reassessment of modified templates","volume":"104","author":"Large","year":"2009","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ucl.2015.04.004_bib55","first-page":"237","article-title":"Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation","volume":"149","author":"Donohue","year":"1993","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.ucl.2015.04.004_bib56","first-page":"1721","article-title":"Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection","volume":"163","author":"Hermans","year":"2000","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.ucl.2015.04.004_bib57","first-page":"2097","article-title":"Retroperitoneal lymph node dissection in patients with high risk testicular cancer","volume":"181","author":"Williams","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"18","key":"10.1016\/j.ucl.2015.04.004_bib58","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1200\/JCO.2007.12.0899","volume":"26","author":"Albers","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.ucl.2015.04.004_bib59","first-page":"1160","article-title":"Clinical stage 1 testicular cancer: the role of modified retroperitoneal lymphadenectomy","volume":"144","author":"Richie","year":"1990","journal-title":"J\u00a0Urol"},{"issue":"2 Pt 1","key":"10.1016\/j.ucl.2015.04.004_bib60","first-page":"424","article-title":"Complications of primary retroperitoneal lymph node dissection","volume":"152","author":"Baniel","year":"1994","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2015.04.004_bib61","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/bju.12804","article-title":"Robot-assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients","volume":"115","author":"Cheney","year":"2015","journal-title":"BJU Int"},{"issue":"11","key":"10.1016\/j.ucl.2015.04.004_bib62","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1089\/end.2010.0596","article-title":"Laparoscopic retroperitoneal lymph node dissection for low-stage cancer: a Washington University update","volume":"25","author":"Gardner","year":"2011","journal-title":"J\u00a0Endourol"},{"issue":"11","key":"10.1016\/j.ucl.2015.04.004_bib63","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1089\/end.2010.0085","article-title":"Laparoscopic retroperitoneal lymph node dissection with therapeutic intent in men with clinical stage I nonseminomatous germ cell tumors","volume":"24","author":"Guzzo","year":"2010","journal-title":"J\u00a0Endourol"},{"issue":"6","key":"10.1016\/j.ucl.2015.04.004_bib64","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.urology.2007.08.041","article-title":"Oncologic efficacy of laparoscopic RPLND in treatment of clinical stage I nonseminomatous germ cell testicular cancer","volume":"70","author":"Nielsen","year":"2007","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.ucl.2015.04.004_bib65","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.urology.2014.07.054","article-title":"Patterns of performance of retroperitoneal lymph node dissections by American urologists: most retroperitoneal lymph node dissections in the United States are performed by low-volume surgeons","volume":"84","author":"Flum","year":"2014","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.ucl.2015.04.004_bib66","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0959-8049(99)00316-0","article-title":"Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. the Indiana University experience","volume":"36","author":"Behnia","year":"2000","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ucl.2015.04.004_bib67","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0305-7372(96)90019-5","article-title":"Adjuvant therapy for stage I testicular cancer","volume":"22","author":"Cullen","year":"1996","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"10.1016\/j.ucl.2015.04.004_bib68","first-page":"605","article-title":"Adjuvant chemotherapy for stage I non-seminomatous testicular cancer","volume":"84","author":"Abratt","year":"1994","journal-title":"S\u00a0Afr Med J"},{"issue":"2","key":"10.1016\/j.ucl.2015.04.004_bib69","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.eururo.2004.03.022","article-title":"Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and\/or vascular invasion","volume":"46","author":"Chevreau","year":"2004","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2015.04.004_bib70","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.urology.2003.08.045","article-title":"Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis","volume":"63","author":"Amato","year":"2004","journal-title":"Urology"},{"issue":"12","key":"10.1016\/j.ucl.2015.04.004_bib71","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1038\/sj.bjc.6602624","article-title":"Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)","volume":"92","author":"Dearnaley","year":"2005","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.ucl.2015.04.004_bib72","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.urology.2003.10.023","article-title":"Long-term follow-up of Anglian Germ Cell Cancer Group surveillance versus patients with stage 1 nonseminoma treated with adjuvant chemotherapy","volume":"63","author":"Oliver","year":"2004","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.ucl.2015.04.004_bib73","first-page":"163","article-title":"Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis","volume":"179","author":"Westermann","year":"2008","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.ucl.2015.04.004_bib74","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/annonc\/mdu518","article-title":"Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy","volume":"26","author":"Vidal","year":"2015","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2015.04.004_bib75","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1098-2388(199912)17:4<275::AID-SSU9>3.0.CO;2-U","article-title":"Late toxicity following curative treatment of testicular cancer","volume":"17","author":"Kollmannsberger","year":"1999","journal-title":"Semin Surg Oncol"},{"issue":"30","key":"10.1016\/j.ucl.2015.04.004_bib76","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1200\/JCO.2010.29.9362","article-title":"Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study","volume":"28","author":"Haugnes","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.ucl.2015.04.004_bib77","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1200\/JCO.2004.07.178","article-title":"Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy","volume":"22","author":"Kondagunta","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"30","key":"10.1016\/j.ucl.2015.04.004_bib78","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1200\/JCO.2013.50.3409","article-title":"Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study","volume":"31","author":"Fung","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2015.04.004_bib79","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00432-004-0628-x","article-title":"Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer","volume":"131","author":"Wierecky","year":"2005","journal-title":"J\u00a0Cancer Res Clin Oncol"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014315000348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014315000348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:26:43Z","timestamp":1758806803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014315000348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0094014315000348"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2015.04.004","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Stage I Nonseminomatous Germ Cell Tumors","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2015.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}